Owens & Minor to sell Products & Healthcare segment; Q3 adjusted EPS $0.25

ACCENDRA HEALTH INC/VA/

Signed definitive agreement to sell Products & Healthcare Services segment, pivoting to pure-play home-based care.
Q3 continuing ops revenue $697.3M (+1.5% YoY); GAAP loss ($0.07)/share; adjusted EPS $0.25.
Adjusted EBITDA from continuing ops $92.2M in Q3, down 14% YoY; YTD adjusted EBITDA $284.8M up 6%.
Announced nationwide preferred provider partnership to expand home-based care reach.
Transaction expected to simplify capital deployment and focus on Patient Direct growth.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.